Glover, Christopher

Dr. Christopher Glover is an Interventional Cardiologist and Director of the Cardiac Catheterization Laboratory in the Division of Cardiology , Department of Medicine, at the University of Ottawa Heart Institute. He is Associate Professor in the Department of Medicine at the University of Ottawa.

Background

Dr. Glover earned his MD and performed residencies in Internal Medicine at Queen’s University in Kingston, Ontario, and in Cardiology at the Heart Institute. He performed his fellowship in Interventional Cardiology at the Heart Institute.

Dr. Glover sits on several committees, among them the Examination Board for Cardiology and the Specialty Committee in Cardiology, Royal College of Physicians and Surgeons of Canada (FRCPC).

He is the Principal Investigator of one study and a Co-Investigator in eight studies.

Research and clinical interests

Dr. Glover's interests include interventional cardiology for the treatment of acute myocardial infarction, stem cell therapy for cardiac diseases, acute coronary syndrome therapy and ethanol ablation for hypertrophic cardiomyopathy.

Publications

LATEST PUBLICATIONS

  • Le May M, So D, Dionne R, Glover C, Froeschl M, Wells GA, Davies RF, Sherrard H, Maloney J, Marquis JF, O’Brien E, Trickett J, Poirier P, Ryan S, Ha A, Joseph P, Labinaz M. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2008;358:231-240.
  • Allan R, Kass M, Glover C, Haddad H. Cellular transplantation: future therapeutic options. Curr Opin Cardiol 2007 Mar;22(2):104-110 (Review).
  • Mahmoud S, Beauchesne L, Davis D, Glover C. Acute reversible left ventricular dysfunction secondary to ethanol, case report. Can J of Cardiol 2007;23:6.
  • Le May MR, Davies RF, Richard Dionne R, Justin Maloney J, John Trickett J, Derek So D, Ha A, Sherrard H, Glover C, Marquis JF, O'Brien E, Stiell I, Poirier P, Labinaz M. Comparison of early mortality of paramedic-diagnosed ST-segment elevation myocardial infarction with immediate transport to a designated primary percutaneous coronary intervention center to that of similar patients transported to the nearest hospital. Am J Cardiol 2006;98:1329-1333.
  • Mahmoud S, Beauchesne L, Davis D, Glover C. Acute reversible left ventricular dysfunction secondary to ethanol, case report. Can J of Cardiol 2006.

PAPERS IN REFEREED JOURNALS

  • Le May M, So D, Dionne R, Glover C, Froeschl M, Wells GA, Davies RF, Sherrard H, Maloney J, Marquis JF, O’Brien E, Trickett J, Poirier P, Ryan S, Ha A, Joseph P, Labinaz M. A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction. N Engl J Med 2008;358:231-40.
  • Mahmoud S, Beauchesne L, Davis D, Glover C. Acute Reversible Left Ventricular Dysfunction Secondary to Ethanol, Case Report. Can J of Cardiol 2007. volume 23:6.
  • Allan R., Kass M, Glover C, Haddad H. Cellular transplantation: future therapeutic options. Curr Opin Cardiol. 2007 Mar;22(2):104-10. Review.
  • Le May MR, Davies RF, Richard Dionne R, Justin Maloney J, John Trickett J, Derek So D, Ha A, Sherrard H, Glover C, Marquis JF, O'Brien E, Stiell I, Poirier P, Labinaz M. Comparison of Early Mortality of Paramedic-Diagnosed ST-Segment Elevation Myocardial Infarction with Immediate Transport to a Designated Primary Percutaneous Coronary Intervention Center to that of Similar Patients Transported to the Nearest Hospital. Am J Cardiol 2006;98:1329–1333
  • Mahmoud S, Beauchesne L, Davis D, Glover C. Acute Reversible Left Ventricular Dysfunction Secondary to Ethanol, Case Report. Can J of Cardiol 2006
  • Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, Maloney J,
  • McKibbin T, Quinn B, Beanlands RS, Glover C, Marquis JF, O'Brien ER, Williams
  • WL, Higginson LA. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol. 2005 Aug 2; 46(3):417-24.
  • Le May M, Kurdi M, Labinaz M, Glover C, So D, Ryan S, Davies R. Safety of coronary stenting with eptifibatide and ultra-low-dose heparin. Am J Cardiol. 2005 Mar 1; 95(5):630-2.
  • Glover C, Ma X, Chen Y-X, Miller H, John Veinot J, Marino Labinaz M, O'Brien, E. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 2002; 144:702-9
  • O’Brien ER, Glover C, and Labinaz M. Acute Outcome with the Flexicut directional Coronary Atherectomy Catheter for the Treatment of Coronary In-Stent Restenosis. Journal of Invasive Cardiology 2001; 13:618-622.
  • Ma X, Glover C, Miller H, Goldstein J, O’Brien E. Focal arterial transgene expression after local gene delivery. Can J of Cardiology 2001; 17:873-883.
  • Glover C, Le May M, Doucette P, Jelley J, and L Higginson. The Usefulness of the Electrocardiogram in Predicting Stent Patency in Patients Presenting with Recurrent Chest Pain Within One Month of the Procedure. Am J Cardiol 2000; 86(4):458-60.
  • Glover C, O’Brien E. Pathophysiological Insights from Retrieved Tissue. Seminars in Interventional Cardiology. 2000; 5:167-173.

ABSTRACTS

  • Manual Thrombus Aspiration In Patients Undergoing Rescue Percutaneous Coronary Intervention Does Not Alter Microvascular Perfusion: Observations From The Ottawa Heart Institute Rescue Pci Registry. N Gauthier, A Ha, M Le May, M Labinaz, C Glover, D So, Can J Cardiol Vol 24 Suppl E October 2008
  • Safety Of Pre-Discharged Staged Percutaneous Coronary Intervention (Pci) For Patients With Multivessel Coronary Disease Undergoing Emergency Pci For Acute St-Elevation Myocardial Infarction (Stemi): Observations From Ottawa Heart Institute’s (Ohi) Stemi Database. M Rahman, M Labinaz, R Allan, M Fong, D So, C Glover, J Marquis, W Williams, M Froeschl, E O’brien, D Sookur, G Wells, M Le May. Can J Cardiol Vol 24 Suppl E October 2008
  • Coronary Stenosis Assessment With Computed Tomographic Coronary Angiography. M Kass, C Glover, D So, M Labinaz, B Chow, Can J Cardiol Vol 24 Suppl E October 2008
  • Critical Time Intervals In Women Versus Men Treated With Primary Angioplasty For St-Segment Myocardial Infarction. M Fong, M Le May, M Labinaz, D So, C Glover, J Marquis, W Williams, M Froeschl, E O’brien, G Wells Can J Cardiol Vol 24 Suppl E October 2008
  • Impact Of Citywide Systematic Primary Percutaneous Coronary Intervention On Outcomes Of St- Segment Elevation Myocardial Infarction In Elderly Patients. A Syed, M Le May, M Fong, M Labinaz, D So, C Glover, J Marquis, W Williams, M Froeschl, E O’brien, P Joseph, G Wells, Can J Cardiol Vol 24 Suppl E October 2008
  • Completeness Of Revascularization In The Elderly By Percutaneous Coronary Intervention: Insights From The Ottawa Heart Institute Pci Registry. D Sookur, M Labinaz, M Le May, C Glover, Sc Goncalves, D Shukla, M Rahman, D So, Can J Cardiol Vol 24 Suppl E October 2008
  • Door-To-Balloon Time And Survival In Elderly Patients: Time Does Matter. A Syed, M Fong, P Joseph, G Wells, M Labinaz, D So, C Glover, J Marquis, W Williams, M Froeschl, E O’brien, M Le May, Can J Cardiol Vol 24 Suppl E October 2008
  • Alterations In Glucose Metabolism In Revascularized Myocardium. A Anselm, R Beanlands, H Atkins, M Le May, RF Davies, I Burwash, R Dekemp, J Dasilva, C Kelly, A Guo, K Williams, C Glover, Can J Cardiol Vol 24 Suppl E October 2008
  • Gene Dosage Of The Common Variant 9p21 Predicts Left Main Disease And Coronary Artery Bypass Grafting. Featured Research. S Dandona, A Stewart, L Chen, K Williams, D So, E O’brien, C Glover, M Le May, L Vo, Y Qing Wang, M Labinaz, G Wells, R McPherson, R Roberts, Can J Cardiol Vol 24 Suppl E October 2008
  • Impact Of Mean Platelet Volume On Clinical Outcomes After Percutaneous Coronary Intervention. D So, Sc Goncalves, M Le May, C Glover, D Shukla, D Sookur, P Ruchin, I Amhalhal, M Rahman, A Ha, M Labinaz, Can J Cardiol Vol 24 Suppl E October 2008
  • A Safety And Efficacy Study Of Integrilin Plus Unfractionated Heparin Versus Unfractionated Heparin Alone In Patients With Acute St-Segment Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: The Assist Trial. Mr Le May, G Wells, C Glover, D So, M Froeschl, J Marquis, E O’brien, M Turek, A Thomas, T Abarbanel, M Labinaz, Can J Cardiol Vol 24 Suppl E October 2008
  • Ling M, Froeschl M, So D, Marquis JF, O’Brien E, Williams W, Lemay M, Labinaz M, Glover C. Clinical Outcomes Associated with the Use of Drug-Eluting Stents for In-Stent Restenosis Lesions. Can J of Cardiol 2005; 21 suppl C.
  • Vozoris S, Labinaz M, Marquis JF, Lemay M, O’Brien E, Williams W, So D, Glover C. Adherence to Recommendations for the Appropriate Allocation of Drug-Eluting Stents. Can J of Cardiol 2005; 21 suppl C.
Glover, Christopher

Glover, Christopher

Glover, Christopher

BSc (Hons), MD, FRCPC

Appointments and affiliations

Interventional Cardiologist

Director, Cardiac Catheterization Laboratory
University of Ottawa Heart Institute

Associate Professor, Department of Medicine
University of Ottawa